Speciality: Endocrinology
Description:
A warm welcome to all the medical professionals in this interesting session on GENEXT pGHD Summit - Diagnosis and Management of Short Stature
The GENEXT pGHD Summit on the Diagnosis and Management of Short Stature is an essential gathering that focuses on the latest strategies and innovations in understanding and treating short stature in children, particularly those with pediatric growth hormone deficiency (pGHD). This summit brings together leading pediatric endocrinologists, researchers, and healthcare professionals to discuss the complexities of diagnosing short stature, which can be a manifestation of various underlying conditions, including pGHD. Early and accurate diagnosis is critical in identifying the root cause of short stature and determining the most appropriate treatment plan.
At the summit, experts share insights on advanced diagnostic tools and techniques, such as genetic testing and growth hormone stimulation tests, which are crucial for distinguishing between different causes of short stature. The management of short stature, particularly in children with pGHD, is also a key focus. Discussions highlight the latest developments in growth hormone therapies, including the benefits of newer, long-acting formulations that improve patient adherence and outcomes. Additionally, the summit addresses the importance of a multidisciplinary approach that considers not only the physical aspects of short stature but also the psychosocial impacts on the child’s well-being.
Therefore, get an overall knowledge of GENEXT pGHD Summit - Diagnosis<
See More Webinars @ Hidoc Webinars
1.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
2.
Relationship-building key to addressing oncologist shortages in rural care
3.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
4.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
5.
Prostate cancer therapies: AI-based image analysis detects early organ damage
1.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
2.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
3.
Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment
4.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
5.
Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation